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Abstract
Hyperactivity of the hypothalamic-pituitary (rPA) axis is one of the main clinical findings in
depression. F{PA axis is interrelated with glucocorticoid signaling via glucocorticoid
receptors (GCRs). Thus, functional genetic variants on GCRs might influence therapeutic
outcomes in dePression.
The aim of the present study was to investigate the association between three functional
polymorphisms (rs4142 3247, rc6195 and rs6189/rs6190) on GCR and response to fluoxetine
in a group of dePressed Patients.
One hundred newly diagnosed patients completed 6 weeks of fluoxetine treatment' Response
to treatment was defined as a 50yo decrease in Hamilton Rating Scale for depression (HRSD)'
Variants of rs41423247, rs6195 and rs6189irs6190 polynorphisms were determined in
extracted DNAs using PCR-RFLP method'
Regarding rs41423247 polymorphism, carriers of cG and GG genotype responded
signilrcantly better to fluoxetine comparing with CC carriers (P:0'008' OR=3'3' 95ohCl:
1.35-S.07). Moreover, the G allele of ts41423247 polymorphism was strongly associated
with response to fluoxetine (P:0.032,OFt:2.2,gs%Cl= l'09-4'44)' There was no siguificant
association between different genotypes and alleles of rs6195, rs6189/rs6190 variants and
response to fluoxetine (P:0-213 and 0'99 respectively)'
In conclus ion, rs41423247 polymorphism might be a predictor for better response to
fluoxetine. Our findings support the idea that some variants of the GCR might contribute to
inter individual variability of response to antidepressants.
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